AI Science Tracker
EN

Machine Learning and Blood-Targeted Proteomics Enable Early Prediction and Etiological Discrimination of Hypertensive Pregnancy Disorders.

Affiliation not stated in the reviewed material · 30 Jan 2026 · medicine

Discovery

Machine Learning and Blood-Targeted Proteomics Enable Early Prediction and Etiological Discrimination of Hypertensive Pregnancy Disorders.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: An 18-protein SVM based on first-trimester serum proteomics discriminated later preeclampsia from other groups and the FMF screen in this nested case-control study; the paper reports 94% sensitivity and 100% specificity in the study cohort. The model was tuned with repeated five-fold CV and evaluated with ten-fold CV, but its relationship to a separate pilot cohort is not a clinical external validation.

Technology: SVM (polynomial/radial kernels), XGBoost and MLP classified first-trimester LC-MRM-MS protein profiles; the SVM result was compared with FMF screening.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
SVM (polynomial/radial kernels), XGBoost and MLP classified first-trimester LC-MRM-MS protein profiles; the SVM result was compared with FMF screening.
Limitation / still unknown
Particle-swarm hyperparameter tuning used five-times repeated five-fold CV; final model performance used ten-fold CV in the same study cohort. The separate pilot cohort supported biomarker analytical concordance, not clinical model validation.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://mdpi-res.com/d_attachment/ijms/ijms-27-01402/article_deploy/ijms-27-01402.pdf

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.